Washington. Contact Information. Email: Statistics. Technological Capabilities



Similar documents
Georgia. Contact Information. Office: Fax: Statistics. Technological Capabilities

Maryland. Department of Health and Mental Hygiene, Alcohol and Drug Abuse Administration Substance Abuse Agency

Idaho. Contact Information. Fax: (208) Statistics. Technological Capabilities

Delaware. Division of Professional Regulation, Office of Controlled Substances Professional Licensing Agency

Massachusetts. Contact Information. Statistics. Technological Capabilities

New Jersey. Contact Information. Statistics. Technological Capabilities

Illinois. Contact Information. Office: Fax: Statistics. Technological Capabilities

Guam. Contact Information. Statistics. Technological Capabilities

Colorado Prescription Drug Monitoring Program. Department of Regulatory Agencies Division of Professions and Occupations State Board of Pharmacy

American Indian Health Commission for Washington State October 1, 2015

Prescribers required to check PDMP before first prescription for Controled Substances for new patient.

PRESCRIPTION MONITORING PROGRAM STATE PROFILES LOUISIANA

Alaska Prescription Drug Monitoring Program

Achieving Better Care by Monitoring All Prescriptions (ABC-MAP) Act 191 of 2014 Board Meeting April 8, 2015

Prescription Drug Monitoring Programs

2015 ANNUAL REVIEW OF PRESCRIPTION MONITORING PROGRAMS

NOTICE REQUIREMENTS FOR PRESCRIPTION MONITORING PROGRAMS

Prescription Drug Monitoring Program Administrators Guide for Training Law Enforcement

Section 303(g)(2)(G) of the Controlled Substances Act (21 U.S.C. 823(g)(2)(G)) is amended. (1) by striking clause (ii) and inserting the following:

Prescription Drug Monitoring Programs Bill Status Update

The Public Health and Safety Challenges of Treating Chronic Pain: The Medical Perspective. A Proposed CMS Platform

Controlled Substances Prescription Monitoring Program. Dean Wright, RPh Arizona State Board of Pharmacy

Prescription Drug Monitoring Programs: Adopting Best & Promising PDMP Practices

11/26/2012. Implementation of Florida s PDMP. Disclosure

CURES Prescription Drug Monitoring Program

Prescription Drug Monitoring Program Annual Report

Prescription Drug Monitoring Program Center of Excellence at Brandeis

Implementation of Florida s PDMP. Rebecca Poston Program Manager

Pennsylvania s ABC-MAP Program

Prescription Drug Monitoring Program. A Powerful Tool

DEA's New Proposed Regulations For E-Prescribing

STATE PLAN TO PREVENT AND TREAT PRESCRIPTION DRUG ABUSE RECOMMENDATION SUMMARY Governor s Prescription Drug Abuse Prevention Council

For a Healthier America: Reducing Prescription Drug Misuse and Abuse

New Jersey State Legislative Update. Opioid Addiction and Abuse Prevention. Legislative Package Moves Forward

HOUSE OF REPRESENTATIVES STAFF ANALYSIS REFERENCE ACTION ANALYST STAFF DIRECTOR. 1) Health Care Mitchell Collins 2) 3) 4) 5)

The Massachusetts Prescription Monitoring Program

TABLE OF CONTENTS CHAPTER 8 PRESCRIPTION DRUG MONITORING PROGRAM

State of South Dakota Board of Pharmacy Prescription Drug Monitoring Program. User Support Manual

FREQUENTLY ASKED QUESTIONS FOR ELECTRONIC PRESCRIBING OF CONTROLLED SUBSTANCES

Report to the Legislature: Interstate Prescription Data Exchange MN Prescription Monitoring Program

SCOPE OF PRACTICE FOR ARNPS

Technical Assistance Guide. PDMP Suggested Practices to Ensure Pharmacy Compliance and Improve Data Integrity

Medicare Advantage and Part D Fraud, Waste, and Abuse Training. October 2010

Medicare Compliance and Fraud, Waste, and Abuse Training

Board of Pharmacy Legislative Update Allison M. Dudley, J.D. Executive Director Board of Pharmacy. Disclosure. Objectives 9/9/2015

MEETING OF THE DRUG SAFETY AND RISK MANAGEMENT ADVISORY COMMITTEE MEETING: RISKS AND BENEFITS OF HYDROCODONE COMBINATION ANALGESIC PRODUCTS

Arthritis Foundation Position Statement on Biosimilar Substitution

Subject: Health; prescription drugs; Vermont Prescription Monitoring 5 System

NOTICES OF PROPOSED RULEMAKING

FISCAL IMPACT STATEMENT. LS 7351 NOTE PREPARED: Feb 6, 2015 BILL NUMBER: SB 464 BILL AMENDED: Feb 5, 2015

Attribute appropriate and inappropriate services to provider of initial visit

CHAPTER Section 34 of P.L.1970, c.226 (C.24:21-34) is amended to read as follows:

State Advocacy Guide to Prescription Drug Monitoring Program Legislation and Regulations

Training Guide for Florida Practitioners and Pharmacists

Electronic Prescribing In New York State

PRESCRIPTION DRUG ABUSE, ADDICTION AND DIVERSION: OVERVIEW OF STATE LEGISLATIVE AND POLICY INITIATIVES A THREE PART SERIES

Thank you for coming to our San Diego Workshop THIS INITIATIVE IS BEING SUPPORTED BY A SPONSORSHIP FROM PFIZER

History of Prescription Drug Monitoring Programs. PDMP Training and Technical Assistance Center Brandeis University

NCPDP Electronic Prescribing Standards

FREQUENTLY ASKED QUESTIONS FOR ELECTRONIC PRESCRIBING OF CONTROLLED SUBSTANCES

Oregon Prescription Drug Monitoring Program. Terms & Conditions of Account Use Agreement. Statutory Authority:

EPCS FREQUENTLY ASKED QUESTIONS FOR ELECTRONIC PRESCRIBING OF CONTROLLED SUBSTANCES. Revised: January 2016

2015 REPORT Steven W. Schierholt, Esq. Executive Director

OBJECTIVES. ! Understand the rising epidemic of prescription drug abuse in Wyoming. ! Know how to access and use reports from the WORx program

Bureau of Justice Assistance Harold Rogers Prescription Drug Monitoring Program National Meeting 9/23/2014

Fraud Waste and Abuse Training Requirement. To Whom It May Concern:

Drug and Alcohol Testing of Doctors. Medical Negligence Lawsuits. Initiative Statute.

Prescription Drug Abuse

How To Write An Eprescription In Dubai

"Electronic Prescribing of Controlled Substances: Addressing Health Care and Law Enforcement Priorities" Before the Senate Judiciary Committee

Drug and Alcohol Testing of Doctors. Medical Negligence Lawsuits. Initiative Statute.

Training Guide for Delaware Practitioners and Pharmacists Delaware Division of Professional Regulation Prescription Monitoring Program

Transcription:

PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Baumgartner, Chris - Director P O Box 47852 Olympia WA 98504-7852 Office: (360) 236-4806 Fax: (360) 236-2901 Email: Washington Washington State Department of Health Department of Health http://www.doh.wa.gov/pmp prescriptionmonitoring@doh.wa.gov chris.baumgartner@doh.wa.gov ASAP Versions Accepted ASAP 1995 ASAP 1997 ASAP 3/2005 Prescription Review ASAP 4/2007 ASAP 4-1/2010 ASAP 4-2/2011 Pharmacy in-state Pharmacy out-state/mail order Pharmacy out-state other Dispensing doctor Contact Information PDMP region: Garrety, Gary - Operations Program Manager P O Box 47852 Olympia WA 98504-7852 Office: (360) 236-4806 Fax: (360) 236-2901 Email: Technological Capabilities Electronic data transmissio Fax data transmission Mail data transmission Media data transmission Required Data Transmitters Veterinarian Veterans Administration Indian Health Services gary.garrety@doh.wa.gov Data Transmission Methods Allowed West Other data transmission Fax and mail only from Veterinarians per statute Other: Veterinarians - only drugs dispensed for more than 14 days must be reported Data Collection Entity: Vendor Vendor name: Health Information Designs, Inc. (HID) Data Storage Entity: Vendor Vendor name: Health Information Designs, Inc. (HID) Report Generation Entity: Vendor Vendor name: Health Information Designs, Inc. (HID) Data Access Entity: Vendor Vendor name: Health Information Designs, Inc. (HID) Data Access Method: Web Portal/On-Line Statistics Statistics Year: 2014 DEA Registered Prescribers: 38,683 State population: 7,061,530 Data Collection, Storage, Generation and Access DEA Registered Dispensers: 1,301

Interstate data sharing PMPi Hub RxCheck Hub RxSentry Hub HIE method Other Hub Data Access via Health Information Exchang via Electronic Health Recor via Pharmacy Dispensing Syste Controlled Schedules Monitored Schedule II monitored Schedule III monitored Schedule IV monitored Schedule V monitored Data Collection and Dates Collection frequency: 7 Legislation enacted: 07-22-2007 PDMP operational 10-07-2011 Data Sharing List of states involved in sharing: Impediments to data sharing: Waiting for other states to sign the RxSentry MOU and for the multi-hub MOU to be signed Exact Match Probablistic Match Policies and Procedures Monitor other authority Remove from Monitoring Web 24/7 Fax 24/7 Web Business Hours Fax Business Hours Other Patient Matching Other Substances Monitored Probablistic/Manual Matc Other Match for queries Data Request Methods and Hours of Operation Phone Business Hours Email Business Hours Mail Business Hours In-Person Business Hours Other Law/Rule Website: Law/Statute citation: WA Code 70.225 Regulation/Rule citation: WA Admin Code 246-470 Dr Shopper law/statute: Pill Mill law/statute: Pain Clinic law/statute: Data Retention Policy All Information Purged Data Retention Time: Chapter 69.41 RCW and Chapter 69.50 RCW Disclosure law/statute: WA Code 70.225.060 6 years Prescriber Information Purged Dispenser Information Purged Patient Information Purged Drug Information Purged Retain De-Identified Data Record Retention Details: Retain for 6 years after no longer needed for agency business then Transfer to the Washington State Archives. De-Identified Data Retention Details: Relevant Statutes and Rules http://www.doh.wa.gov/forpublichealthandhealthcareproviders/healthcareprofessionsandfacilit ies/prescriptionmonitoringprogrampmp/rules Data Retention

Required Enrollment - Prescriber Required Enrollment - Dispenser PDMP Required Enrollment and Patient Query Required Patient Query - Prescriber Required Patient Query - Dispenser Required Patient Query Details: Workers Comp providers must check the prescription monitoring program data base, if available, and document before prescribing opioids in the subacute phase and repeat during chronic opioid therapy at intervals according to the worker's risk category as described in the agency medical directors' group's guideline. Before the department or self-insurer authorizes payment for opioids beyond the acute phase, the provider must perform and document the following: Access the state's prescription monitoring program data base, if available, to ensure that the controlled substance history is consistent with the prescribing record and the worker's report. An agency providing chemical dependency opiate substitution treatment services must ensure the program physician, or the medical practitioner under supervision of the program physician, performs and meets the following: A review must be completed by the department of health prescription drug monitoring program data on the individual: (a) At admission; (b) Annually after the date of admission; and (c) Subsequent to any incidents of concern. Select Data Fields Available Payment method captured Patient Identification captured Person dropping off captured Person picking up captured Ability to id prescriber specialty Prescriber: Dispenser: Regulatory Board: Law Enforcement: Attorney General: Researcher: Patient: Other: Miscellaneous Capabilities and Policies Authority to release de-identified data Ability to de-identified data Authority to release for epidemiological or educational purposes Engaged in release for epidemiological or educational purposes Required Notification to consumers Mandated Use of Advisory Group Patient Access to Query List Requirements to Query PDMP To register, a prescriber who has a WA license can register online using information from their DEA registration and state health professional license. We are also adding a driver s license check. For nonresident prescribers a form can be filled out online, printed, signed, notarized, and mailed in. Prescriber Access to Patient History Prescriber Access to Own History Dispenser Access to Patient History Dispenser Access to Own History PDMP Available Reports Available Reports to Selected Requestors Licensing Board Access to Patient History Licensing Board Access to Licensee History Law Enforcement Access to Patient History Law Enforcement Access to Prescriber History Law Enforcement Access to Dispenser History

Requestors and Reports Authorized to Generate Requestor Type Prescriber Dispenser/Business (i.e., pharmacy) Dispenser/Person (i.e., pharmacist) Midlevel - Physician Assistant Midlevel - Nurse Practitioner Prescriber Delegate Dispenser Delegate Patient Law Enforcement - Federal Law Enforcement - State Law Enforcement - Local Prosecutorial Authority Correctional Supervision Drug Court Licensing/Regulatory Board State Health Department Medicaid Fraud and Abuse Medicaid Drug Utilization and Review Medicare Workers Compensation - State Workers Compensation - Insurance Peer Review Committee Drug Treatment Provider Third-party Payer Researchers Other PDMP Solicited Reports Unsolicited Reports In-State Out-of-State In-State Out-of-State

Requestors and Reports Being Generated Requestor Type Prescriber Dispenser/Business (i.e., pharmacy) Dispenser/Person (i.e., pharmacist) Midlevel - Physician Assistant Midlevel - Nurse Practitioner Prescriber Delegate Dispenser Delegate Patient Law Enforcement - Federal Law Enforcement - State Law Enforcement - Local Prosecutorial Authority Correctional Supervision Drug Court Licensing/Regulatory Board State Health Department Medicaid Fraud and Abuse Medicaid Drug Utilization and Review Medicare Workers Compensation - State Workers Compensation - Insurance Peer Review Committee Drug Treatment Provider Third-party Payer Researchers Other PDMP Solicited Reports Unsolicited Reports In-State Out-of-State In-State Out-of-State